These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

705 related items for PubMed ID: 22869222

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents.
    Williams RJ, Goodale LA, Shay-Fiddler MA, Gloster SP, Chang SY.
    Am J Addict; 2004; 13(4):381-9. PubMed ID: 15370936
    [Abstract] [Full Text] [Related]

  • 23. Illicit use of prescription ADHD medications on a college campus: a multimethodological approach.
    DeSantis AD, Webb EM, Noar SM.
    J Am Coll Health; 2008; 57(3):315-24. PubMed ID: 18980888
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment.
    Torres AR, Whitney J, Gonzalez-Heydrich J.
    Epilepsy Behav; 2008 Feb; 12(2):217-33. PubMed ID: 18065271
    [Abstract] [Full Text] [Related]

  • 26. Managing stimulant medication for attention-deficit/hyperactivity disorder.
    Wender EH.
    Pediatr Rev; 2001 Jun; 22(6):183-90. PubMed ID: 11389305
    [No Abstract] [Full Text] [Related]

  • 27. Safety of medicines used for ADHD in children: a review of published prospective clinical trials.
    Clavenna A, Bonati M.
    Arch Dis Child; 2014 Sep; 99(9):866-72. PubMed ID: 24748641
    [Abstract] [Full Text] [Related]

  • 28. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA, Pliszka SR.
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Attention deficit hyperactivity disorder in adults.
    Rösler M, Casas M, Konofal E, Buitelaar J.
    World J Biol Psychiatry; 2010 Aug; 11(5):684-98. PubMed ID: 20521876
    [Abstract] [Full Text] [Related]

  • 31. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
    Merkel RL, Kuchibhatla A.
    Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
    [Abstract] [Full Text] [Related]

  • 32. The use of lisdexamfetamine dimesylate for the treatment of ADHD.
    Childress AC, Sallee FR.
    Expert Rev Neurother; 2012 Jan; 12(1):13-26. PubMed ID: 22243042
    [Abstract] [Full Text] [Related]

  • 33. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
    Coghill D, Banaschewski T, Lecendreux M, Soutullo C, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Lyne A, Squires L.
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety.
    Heal DJ, Cheetham SC, Smith SL.
    Neuropharmacology; 2009 Dec; 57(7-8):608-18. PubMed ID: 19761781
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.